
Caladan Bio is a pioneering company focused on innovative bioreactor technology, aiming to transform synthetic biology through affordable, cutting-edge bioreactors and advanced software. Their proprietary data infrastructure and machine learning technologies enhance the design, prototyping, and scaling of fermentation experiments, positioning them as a leader in biomanufacturing.

Caladan Bio is a pioneering company focused on innovative bioreactor technology, aiming to transform synthetic biology through affordable, cutting-edge bioreactors and advanced software. Their proprietary data infrastructure and machine learning technologies enhance the design, prototyping, and scaling of fermentation experiments, positioning them as a leader in biomanufacturing.
Founded: 2023
Headquarters: Brooklyn, New York
Product focus: Modular high-throughput benchtop bioreactors (Caladan 250) and integrated software (CaladanOS)
Seed funding: $5.0M (announced Feb 13, 2024)
Employee count: 13
Bioprocess development, fermentation experiment design/prototyping, and scale-up for synthetic biology/biomanufacturing.
2023
Biotechnology Research
$5.0M
Round includes participation from Wireframe Ventures, Ritual Capital, Lerer Hippeau, Factorial Capital, and Collaborative Fund.
“Syndicate of early-stage VC firms with a lead investor (Twelve Below)”
| Company |
|---|